344 related articles for article (PubMed ID: 21194028)
1. Engineering exon-skipping vectors expressing U7 snRNA constructs for Duchenne muscular dystrophy gene therapy.
Goyenvalle A; Davies KE
Methods Mol Biol; 2011; 709():179-96. PubMed ID: 21194028
[TBL] [Abstract][Full Text] [Related]
2. Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapy.
Goyenvalle A; Babbs A; van Ommen GJ; Garcia L; Davies KE
Mol Ther; 2009 Jul; 17(7):1234-40. PubMed ID: 19455105
[TBL] [Abstract][Full Text] [Related]
3. Engineering multiple U7snRNA constructs to induce single and multiexon-skipping for Duchenne muscular dystrophy.
Goyenvalle A; Wright J; Babbs A; Wilkins V; Garcia L; Davies KE
Mol Ther; 2012 Jun; 20(6):1212-21. PubMed ID: 22354379
[TBL] [Abstract][Full Text] [Related]
4. Engineering U7snRNA gene to reframe transcripts.
Goyenvalle A
Methods Mol Biol; 2012; 867():259-71. PubMed ID: 22454067
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
Echigoya Y; Lim KRQ; Trieu N; Bao B; Miskew Nichols B; Vila MC; Novak JS; Hara Y; Lee J; Touznik A; Mamchaoui K; Aoki Y; Takeda S; Nagaraju K; Mouly V; Maruyama R; Duddy W; Yokota T
Mol Ther; 2017 Nov; 25(11):2561-2572. PubMed ID: 28865998
[TBL] [Abstract][Full Text] [Related]
6. Long-term restoration of cardiac dystrophin expression in golden retriever muscular dystrophy following rAAV6-mediated exon skipping.
Bish LT; Sleeper MM; Forbes SC; Wang B; Reynolds C; Singletary GE; Trafny D; Morine KJ; Sanmiguel J; Cecchini S; Virag T; Vulin A; Beley C; Bogan J; Wilson JM; Vandenborne K; Kornegay JN; Walter GA; Kotin RM; Garcia L; Sweeney HL
Mol Ther; 2012 Mar; 20(3):580-9. PubMed ID: 22146342
[TBL] [Abstract][Full Text] [Related]
7. Chimeric adeno-associated virus/antisense U1 small nuclear RNA effectively rescues dystrophin synthesis and muscle function by local treatment of mdx mice.
Denti MA; Rosa A; D'Antona G; Sthandier O; De Angelis FG; Nicoletti C; Allocca M; Pansarasa O; Parente V; Musarò A; Auricchio A; Bottinelli R; Bozzoni I
Hum Gene Ther; 2006 May; 17(5):565-74. PubMed ID: 16716113
[TBL] [Abstract][Full Text] [Related]
8. AAV genome loss from dystrophic mouse muscles during AAV-U7 snRNA-mediated exon-skipping therapy.
Le Hir M; Goyenvalle A; Peccate C; Précigout G; Davies KE; Voit T; Garcia L; Lorain S
Mol Ther; 2013 Aug; 21(8):1551-8. PubMed ID: 23752313
[TBL] [Abstract][Full Text] [Related]
9. Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.
Goyenvalle A; Babbs A; Wright J; Wilkins V; Powell D; Garcia L; Davies KE
Hum Mol Genet; 2012 Jun; 21(11):2559-71. PubMed ID: 22388933
[TBL] [Abstract][Full Text] [Related]
10. U7 snRNAs induce correction of mutated dystrophin pre-mRNA by exon skipping.
Brun C; Suter D; Pauli C; Dunant P; Lochmüller H; Burgunder JM; Schümperli D; Weis J
Cell Mol Life Sci; 2003 Mar; 60(3):557-66. PubMed ID: 12737315
[TBL] [Abstract][Full Text] [Related]
11. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping.
Goyenvalle A; Vulin A; Fougerousse F; Leturcq F; Kaplan JC; Garcia L; Danos O
Science; 2004 Dec; 306(5702):1796-9. PubMed ID: 15528407
[TBL] [Abstract][Full Text] [Related]
12. MRI roadmap-guided transendocardial delivery of exon-skipping recombinant adeno-associated virus restores dystrophin expression in a canine model of Duchenne muscular dystrophy.
Barbash IM; Cecchini S; Faranesh AZ; Virag T; Li L; Yang Y; Hoyt RF; Kornegay JN; Bogan JR; Garcia L; Lederman RJ; Kotin RM
Gene Ther; 2013 Mar; 20(3):274-82. PubMed ID: 22551778
[TBL] [Abstract][Full Text] [Related]
13. Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells.
De Angelis FG; Sthandier O; Berarducci B; Toso S; Galluzzi G; Ricci E; Cossu G; Bozzoni I
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9456-61. PubMed ID: 12077324
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy.
Wang Q; Yin H; Camelliti P; Betts C; Moulton H; Lee H; Saleh AF; Gait MJ; Wood MJ
J Gene Med; 2010 Apr; 12(4):354-64. PubMed ID: 20235089
[TBL] [Abstract][Full Text] [Related]
15. Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping.
Vulin A; Barthélémy I; Goyenvalle A; Thibaud JL; Beley C; Griffith G; Benchaouir R; le Hir M; Unterfinger Y; Lorain S; Dreyfus P; Voit T; Carlier P; Blot S; Garcia L
Mol Ther; 2012 Nov; 20(11):2120-33. PubMed ID: 22968479
[TBL] [Abstract][Full Text] [Related]
16. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
Lee JJA; Saito T; Duddy W; Takeda S; Yokota T
Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539
[TBL] [Abstract][Full Text] [Related]
17. Full-length dystrophin restoration via targeted exon integration by AAV-CRISPR in a humanized mouse model of Duchenne muscular dystrophy.
Pickar-Oliver A; Gough V; Bohning JD; Liu S; Robinson-Hamm JN; Daniels H; Majoros WH; Devlin G; Asokan A; Gersbach CA
Mol Ther; 2021 Nov; 29(11):3243-3257. PubMed ID: 34509668
[TBL] [Abstract][Full Text] [Related]
18. Exon skipping and duchenne muscular dystrophy therapy: selection of the most active U1 snRNA antisense able to induce dystrophin exon 51 skipping.
Incitti T; De Angelis FG; Cazzella V; Sthandier O; Pinnarò C; Legnini I; Bozzoni I
Mol Ther; 2010 Sep; 18(9):1675-82. PubMed ID: 20551908
[TBL] [Abstract][Full Text] [Related]
19. Absence of Significant Off-Target Splicing Variation with a U7snRNA Vector Targeting
Wein N; Dunn DM; Waldrop MA; Gushchina LV; Frair EC; Weiss RB; Flanigan KM
Hum Gene Ther; 2021 Nov; 32(21-22):1346-1359. PubMed ID: 34060935
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.
Nakamura A; Aoki Y; Tsoumpra M; Yokota T; Takeda S
Methods Mol Biol; 2018; 1828():151-163. PubMed ID: 30171540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
